- Home
- GRFS vs INSP Comparison
GRFS vs INSP Comparison
Compare GRFS & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRFS
- INSP
- Stock Information
- Founded
- GRFS 1940
- INSP 2007
- Country
- GRFS Spain
- INSP United States
- Employees
- GRFS N/A
- INSP N/A
- Industry
- GRFS Biotechnology: Pharmaceutical Preparations
- INSP Medical/Dental Instruments
- Sector
- GRFS Health Care
- INSP Health Care
- Exchange
- GRFS Nasdaq
- INSP Nasdaq
- Market Cap
- GRFS 6.0B
- INSP 5.2B
- IPO Year
- GRFS 2006
- INSP 2018
- Fundamental
- Price
- GRFS $9.45
- INSP $172.77
- Analyst Decision
- GRFS Sell
- INSP Buy
- Analyst Count
- GRFS 2
- INSP 11
- Target Price
- GRFS $10.50
- INSP $226.18
- AVG Volume (30 Days)
- GRFS 1.0M
- INSP 570.0K
- Earning Date
- GRFS 01-01-0001
- INSP 11-04-2024
- Dividend Yield
- GRFS N/A
- INSP N/A
- EPS Growth
- GRFS N/A
- INSP N/A
- EPS
- GRFS 0.27
- INSP 1.09
- Revenue
- GRFS $7,814,096,584.00
- INSP $755,594,000.00
- Revenue This Year
- GRFS $8.86
- INSP $29.96
- Revenue Next Year
- GRFS $7.00
- INSP $19.42
- P/E Ratio
- GRFS $41.33
- INSP $157.93
- Revenue Growth
- GRFS 7.21
- INSP 32.52
- 52 Week Low
- GRFS $5.30
- INSP $123.00
- 52 Week High
- GRFS $12.15
- INSP $257.40
- Technical
- Relative Strength Index (RSI)
- GRFS 62.73
- INSP 34.22
- Support Level
- GRFS $8.69
- INSP $196.12
- Resistance Level
- GRFS $9.75
- INSP $204.93
- Average True Range (ATR)
- GRFS 0.37
- INSP 10.27
- MACD
- GRFS 0.06
- INSP -2.67
- Stochastic Oscillator
- GRFS 80.27
- INSP 5.77
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.